Terms: = Germ cell tumor AND KIAA1549, ENSG00000122778, 57670 AND Clinical Outcome
3 results:
1. Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
Bennebroek CA; Schouten CR; Montauban-van Swijndregt MC; Saeed P; Porro GL; Pott JWR; Dittrich ATM; Oostenbrink R; Schouten-van Meeteren AY; de Jong MC; de Graaf P
J Neurooncol; 2024 Jan; 166(1):79-87. PubMed ID: 38150061
[TBL] [Abstract] [Full Text] [Related]
2. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
[TBL] [Abstract] [Full Text] [Related]
3. BRAF-kiaa1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.
Hawkins C; Walker E; Mohamed N; Zhang C; Jacob K; Shirinian M; Alon N; Kahn D; Fried I; Scheinemann K; Tsangaris E; Dirks P; Tressler R; Bouffet E; Jabado N; Tabori U
Clin Cancer Res; 2011 Jul; 17(14):4790-8. PubMed ID: 21610142
[TBL] [Abstract] [Full Text] [Related]
